###begin article-title 0
###xml 79 87 <span type="species:ncbi:9606">Patients</span>
Cytokine Gene Polymorphisms across Tuberculosis Clinical Spectrum in Pakistani Patients
###end article-title 0
###begin p 1
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
Performed the experiments: AA NT. Analyzed the data: AA NT. Wrote the paper: AA. Extra pulmonary patients recruitment and diagnosis: BJ. Optimization of PCR conditions and training: ZH. Design of experiment and critical reading of the manuscript: TR. Recruitment of Pulmonary patients and diagnosis: GD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 694 695 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 695 697 687 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 700 701 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 701 703 691 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 719 720 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 720 722 710 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 725 726 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 726 728 714 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 746 754 <span type="species:ncbi:9606">patients</span>
Pakistan ranks 7th globally in terms of tuberculosis (TB) disease burden (incidence 181/100000 pop./yr; prevalence of 329/pop./yr). Reports from different populations show variable associations of TB susceptibility and severity with cytokine gene polymorphisms. Tuberculosis clinical severity is multi-factorial and cytokines play a pivotal role in the modulation of disease severity. We have recently reported that the ratio of two key cytokines (IFNgamma and IL10) show significant correlation with the severity spectrum of tuberculosis. The objective of the current study was to analyze the frequency of cytokine gene polymorphisms linked to high and low responder phenotypes (IFNgamma +874 Thi-->Alo and IL10 -1082 Glo-->Ahi) in tuberculosis patients.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 506 508 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 522 523 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 603 605 595 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 631 633 623 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 633 635 625 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 681 682 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 723 724 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 743 745 729 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 745 747 731 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 791 793 777 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 793 795 779 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
Study groups were stratified according to disease site as well as disease severity: Pulmonary N = 111 (Minimal, PMN = 19; Moderate, PMD = 63; Advance, PAD = 29); Extra-pulmonary N = 67 (Disseminated DTB = 20, Localized LTB = 47) and compared with healthy controls (TBNA = 188). Genotype analyses were carried out using amplification refractory mutation system-PCR (ARMS-PCR) and stimulated whole blood (WB) culture assay was used for assessing cytokine profiles. Our results suggest that the IFNgamma +874 TT genotype and T allele was overrepresented in PMN (p = 0.01) and PMD (p = 0.02). IFNgamma +874 TT in combination with IL10 GGlo genotypes showed the highest association (chi2 = 6.66, OR = 6.06, 95% CI = 1.31-28.07, p = 0.01). IFNgamma AAlo on the other hand in combination with IL10 GGlo increased the risk of PAD (OR = 5.26; p = 0.005) and DTB (OR = 3.59; p = 0.045).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
These findings are consistent with the role of IL10 in reducing collateral tissue damage and the protective role of IFNgamma in limiting disease in the lung.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Akhtar1">[1]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Lemos1">[4]</xref>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Comstock1">[5]</xref>
###xml 855 858 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Ferraz1">[6]</xref>
###xml 1145 1148 1141 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Dorman1">[7]</xref>
###xml 1150 1153 1146 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Altare1">[8]</xref>
###xml 1407 1410 1399 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Pacheco1">[9]</xref>
###xml 1426 1427 1414 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1427 1429 1415 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1432 1433 1418 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1433 1435 1419 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 1536 1537 1522 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1598 1602 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Pravica1">[10]</xref>
###xml 1636 1640 1618 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Rees1">[11]</xref>
###xml 1815 1819 1797 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Ates1">[12]</xref>
###xml 1821 1825 1803 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Oh1">[13]</xref>
###xml 1960 1964 1938 1942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Flynn1">[14]</xref>
###xml 2064 2071 2042 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 2282 2286 2256 2260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-OGarra1">[15]</xref>
###xml 2457 2461 2427 2431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Jamil1">[16]</xref>
###xml 2648 2649 2610 2611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 2649 2651 2611 2613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 2654 2655 2614 2615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 2655 2657 2615 2617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 2673 2674 2633 2634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 2674 2676 2634 2636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 2679 2680 2637 2638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 2680 2682 2638 2640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 2864 2867 2818 2821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1095 1101 <span type="species:ncbi:9606">humans</span>
###xml 1795 1802 <span type="species:ncbi:9606">patient</span>
Pakistan ranks 7th globally in terms of tuberculosis disease burden with an incidence of 181/100000 pop./yr and a prevalence of 329/ pop. /yr. Several reports from different countries have shown that household contacts of active pulmonary tuberculosis are at much higher risk of latent infection that range from 30-80% depending on the intensity of tuberculosis disease transmission [1]-[4]. Only ten percent of those latently infected individuals develop TB disease during their lifetime [5]. Identification of these high-risk individuals in recently exposed/ infected individuals is of great importance to TB Control Programs for reducing the disease burden in the community. Association of pathological severity with increased circulating levels of different pro-inflammatory and or down-regulatory cytokines in tuberculosis is fairly well established [6]. An increasing number of studies have shown that single nucleotide polymorphisms (SNPs) located in the promoter or coding regions of cytokine genes result in differential cytokine secretion due to altered transcriptional activation. In humans, families with SNPs in IFNgamma receptor 1 [7], [8] genes have shown Mendelian susceptibility to tuberculosis. Single nucleotide polymorphisms (SNPs) located in the first intron of the IFNgamma gene (at position +874) have shown variable associations with tuberculosis disease susceptibility and severity [9]. IFNgamma (+874Thi-->Alo) polymorphism is located within a putative NF-kb binding site and shows preferential binding to the T allele and correlates with high IFNgamma producer phenotype [10]. Similarly polymorphisms in IL10 [11] linked to high and low producer phenotypes have shown conflicting associations with tuberculosis disease susceptibility and disease severity in different patient populations [12], [13]. This is not surprising as, although IFNgamma may be a key cytokine in activation of macrophages for mycobacterial stasis and killing [14], disease severity outcomes in tuberculosis depend on the balance among several different cytokines in situ, depending on the disease site. IL10 is particularly important in reducing collateral tissue damage, particularly in the lung by dampening macrophage activation and by indirectly antagonizing IFNgamma function [15]. We have recently reported that the ratio of these two key cytokines (IFNgamma/IL10) shows significant correlation with clinical severity in extra-pulmonary tuberculosis [16],with higher IFNgamma/IL10 ratio relating to less severe disease. We have now extended these studies to analyze the frequency of high and low responder cytokine phenotypes (IFNgamma +874 Thi-->Alo and IL10 -1082 Glo-->Ahi) to analyze the relationship of these SNPs with clinical severity of tuberculosis. Our results show that SNPs in IFNgamma are significantly related to site of TB disease (Pulmonary vs. Extrapulmonary) while combinations of SNPs in IFNgamma and IL10 genes are important determinants of TB disease severity. Our results therefore substantiate our aim of the study.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Demographic characteristics of the study groups
###end title 11
###begin p 12
###xml 69 76 69 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t001">Table 1</xref>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
There were no significant differences in age in TBNA and TBA groups (Table 1). The ratio of females was significantly higher (p<0.05) in TBA compared to TBNA. However, no significant association of genotype with age or sex was observed in both TBA and TBNA (>0.05) using multiple logistic regression analysis (data not shown).
###end p 12
###begin title 13
###xml 34 42 <span type="species:ncbi:9606">Patients</span>
Demographic characteristics of TB Patients and Controls.
###end title 13
###begin p 14
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</bold>
###xml 44 65 44 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 6 13 <span type="species:ncbi:9606">Patient</span>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
Note: Patient stratification is as given in Materials and Methods. Abbreviations for groups are given in brackets. TBA included 10 previously treated patients.
###end p 14
###begin title 15
###xml 56 57 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 57 59 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 62 63 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 63 65 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 83 84 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 84 86 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 89 90 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 90 92 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
Relationship of genotype and phenotype of IFNgamma (+874Thi-->Alo) and IL10 (-1082 Glo-->Ahi) in TBNA
###end title 15
###begin p 16
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004778-g001">Figure 1</xref>
###xml 144 146 140 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 143 146 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T<sup>hi</sup></italic>
###xml 149 150 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 150 152 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 170 171 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 171 173 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 176 177 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 177 179 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 199 201 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 211 213 199 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
Figure 1 shows the relationship of cytokine secretion in response to mycobacterial antigen stimulation with different genotypes IFNgamma (+874 Thi-->Alo) and IL10 (-1082 Glo-->Ahi).We found IFNgamma TT and IL10 AA to be the high producer phenotype in response to mycobacterial antigens. We next looked at the frequency of these genotypes in association with disease severity.
###end p 16
###begin title 17
Relationship of IFNgamma and IL10 SNPs with mycobacterial antigen induced cytokine secretion.
###end title 17
###begin p 18
###xml 97 112 97 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 279 299 271 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
###xml 97 112 <span type="species:ncbi:1773">M. tuberculosis</span>
Whole blood from TB not affected (TBNA) Tuberculin skin test positive donors was stimulated with M. tuberculosis culture filtrate (CF) proteins [5 microg/ml] and supernatants tested at 2 days for IL10 secretion and day 5 for IFNgamma secretion using ELISA method as described in material and methods. Results are expressed as pg/ml after deducting secretion in un-stimulated whole blood.
###end p 18
###begin title 19
Distinct IFNgamma +874 but not IL10 -1082 genotype SNPs are associated with different disease sites and not with TB susceptibility
###end title 19
###begin p 20
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t003">Tables 3</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t004">4</xref>
###xml 130 131 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 134 135 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 229 230 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 249 250 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 381 382 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 437 438 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 501 502 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 50 57 <span type="species:ncbi:9606">patient</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
Cytokine genotypes and alleles frequencies in all patient groups were compared with healthy controls (Tables 3 & 4). IFNgamma +874T-->A genotype distribution was in Hardy-Weinberg equilibrium for both patients and controls (TBA; p = 0.607 and TBNA; p = 1.0). On the other hand, IL-10 -1082G-->A polymorphism showed deviation from HWE due to excess of heterozygosity (TBA and TBNA; p = 0.00004). Cases and controls were compared using chi2, odds ratios (OR) and their confidence intervals, (95% CI). A p value of <0.05 was considered significant. Different cytokine genotypes and alleles showed distinct associations with different disease types as described below.
###end p 20
###begin p 21
###xml 14 16 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 70 71 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 80 81 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 92 99 86 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t003">Table 3</xref>
###xml 151 158 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t004">Table 4</xref>
###xml 380 383 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 506 508 496 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 532 539 522 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t003">Table 3</xref>
###xml 630 633 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 719 722 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 807 814 <span type="species:ncbi:9606">patient</span>
IFNgamma +874 TT genotype showed significant association with PTB (chi2 = 6.05, p = 0.034) (Table 3). This association was restricted to the T allele (Table 4). In terms of disease severity in the lung this association was restricted to PMN and PMD and was not seen with PAD. Similarly, no association was observed with ETB or stratified ETB on the basis of disease severity (DTB vs. LTB). When we compared healthy controls with latent infection (TST+) similar and much more marked effect of IFNgamma +874 TT genotype was observed (Table 3). Therefore, genotype associations were not only different according to disease site (PTB vs. ETB) but there was a distinct difference between severity within a disease site (PMD vs. PAD). These results therefore suggest that it is inappropriate to pool tuberculosis patient with differing sites and even severity within individual sites.
###end p 21
###begin p 22
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t003">Table 3</xref>
###xml 154 161 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t004">Table 4</xref>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t004">Table 4</xref>
###xml 396 398 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Mehdi1">[17]</xref>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
Table 3 also shows the frequency of IL10 -1082 genotype in relation to disease site as well as disease severity. Neither IL10 -1082 genotype nor alleles (Table 4) show any association in relation to either site or severity of tuberculosis. The p values were similar when patients were compared with TST+ controls (Table 4). There was an overrepresentation of the IL10 -1082 heterozygous genotype GA in both controls and PTB as well as ETB. Linkage disequilibrium is not uncommon in consangious populations such as where the study is being conducted. [17]
###end p 22
###begin title 23
Multiloci genotype association with risk of disease severity across the tuberculosis disease spectrum
###end title 23
###begin p 24
###xml 96 100 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Jamil1">[16]</xref>
###xml 426 433 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t005">Table 5</xref>
###xml 471 478 463 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t003">Table 3</xref>
###xml 522 524 510 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 524 526 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 567 569 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 565 569 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA<sup>lo</sup></italic>
###xml 744 746 728 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 746 748 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 780 782 760 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 778 782 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA<sup>lo</sup></italic>
###xml 840 841 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
We have previously shown that IFNgamma/IL10 ratio is a critical determinant of disease severity [16]. Since both cytokines (IFNgamma, IL10) showed distinct associations with different sites and severity of TB, we also assessed if genotype combinations for these two cytokines may contribute to increased risk of TB with respect to site or severity. There were nine possible combinations. Only significant results are shown in Table 5. As expected from previous analyses (Table 3) there was a clear association of IFNgamma TThi with pulmonary disease while IFNgamma AAlo was clearly associated with increased risk of PAD and DTB. The effect of IL10 genotype combination was much more evident with disease site rather than disease severity. IL10 GGlo in combination with IFNgamma AAlo was associated with the highest risk for DTB (OR = 3.59; p = 0.045). The results were similar when cases were compared with TST+ controls.
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
###xml 372 374 372 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 374 376 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
Although the effect of cytokine gene polymorphisms (SNPs) on tuberculosis disease sites or disease severity have been reported in different populations, our results for the first time show differential association of cytokine genotype combinations with either pulmonary or extra-pulmonary disease. We also report that in the lung compartment the high responder IL10 -1082 AAhi may play a critical role in limiting tissue damage in PTB. Because of careful characterization of disease in each of the group, we are able to show significant differences between groups and among groups. In addition, differences seen in both cytokines SNPs can be reconciled with their biological function. We feel that this is a very important issue despite small numbers in the stratified groups. When pulmonary patients are not stratified the sample size is sufficient for power of statistics. We have therefore given results for both pooled and stratified groups. There are very few studies, which relate genotype to phenotype. This is the strength of the current study.
###end p 26
###begin p 27
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Bagheri1">[18]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Takiff1">[19]</xref>
###xml 303 304 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 304 306 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 309 310 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 310 312 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 462 463 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 510 511 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 556 560 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Lio1">[20]</xref>
###xml 576 580 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Rossouw1">[21]</xref>
###xml 599 603 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Tso1">[22]</xref>
###xml 627 631 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-LopezMaderuelo1">[23]</xref>
###xml 678 682 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Oral1">[24]</xref>
###xml 758 759 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 767 771 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Sallakci1">[25]</xref>
###xml 784 788 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Etokebe1">[26]</xref>
###xml 809 810 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 868 871 862 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 978 982 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Moran1">[27]</xref>
###xml 1012 1016 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Vidyarani1">[28]</xref>
###xml 1054 1058 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Henao1">[29]</xref>
###xml 1097 1098 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1253 1254 1239 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1387 1394 1373 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t004">Table 4</xref>
###xml 1634 1638 1620 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Pravica1">[10]</xref>
###xml 1640 1644 1626 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Vidyarani1">[28]</xref>
###xml 1646 1650 1632 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Cooke1">[30]</xref>
###xml 1651 1655 1637 1641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Sahiratmadja1">[32]</xref>
###xml 1722 1724 1708 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 1724 1726 1710 1712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1786 1788 1768 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 1788 1790 1770 1772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1812 1814 1794 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 1887 1891 1869 1873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Turner1">[33]</xref>
###xml 1954 1958 1936 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Hussain1">[34]</xref>
###xml 2004 2008 1986 1990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Turner1">[33]</xref>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 636 642 <span type="species:ncbi:9103">Turkey</span>
###xml 884 892 <span type="species:ncbi:9606">patients</span>
###xml 1277 1285 <span type="species:ncbi:9606">patients</span>
###xml 1313 1321 <span type="species:ncbi:9606">patients</span>
There are considerable variations in allelic frequencies of cytokine gene polymorphisms in different populations [18] and therefore it is not surprising that genetic polymorphisms associated with tuberculosis have yielded conflicting results in different ethnic groups [19]. IFNgamma polymorphism (+874 Thi-->Alo) is the most studied polymorphism in terms of association with tuberculosis disease sites and severity. However, the reports are conflicting in that A allele is more common in patients with TB and T alleles, more common in controls in Italian [20], South African [21] Hong Kong Chinese [22]and Spanish populations [23]. In Turkey, one study reported no association [24], while a later study in the same population showed an association with the A allele [25]. In Croatia [26] an association with A allele was found only in microscopy and culture positive vs. negative TB patients. On the other hand, no association has been reported in Caucasians in Houston, Texas [27] and South Indian populations [28]. There is only one study in Colombia [29] where an association of IFNgamma +874 T allele with the more localized pleural disease has been observed. Our results are in agreement with the latter study. We show that the effect of IFNgamma T allele in TB affected patients is restricted to pulmonary patients with minimal/ moderate disease increasing the risk by 2-3 folds (Table 4). Both our study and the Colombian study show a much more marked association with the more protective form of tuberculosis. Some of the differences could be due to the influence of other genes linked to tuberculosis disease susceptibility [10], [28], [30]-[32]. As shown in our study, the presence of high responder IL10 -1082 AAhi may limit lung tissue damage when associated with IFNgamma TThi. Turner has reported AA to be a low producer phenotype in response to mitogenic (ConA) stimulus [33]. Mycobacterial antigens are potent stimulators of macrophages [34] while Con A is primarily a T cell stimulator [33]. Therefore, it is possible that different stimuli may result in differential transcription of the same gene. For the current study we considered mycobacterial antigens to be the more appropriate stimulus.
###end p 27
###begin p 28
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 57 58 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 58 60 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 109 113 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Bellamy1">[35]</xref>
###xml 122 126 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Shin1">[36]</xref>
###xml 139 143 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-LopezMaderuelo1">[23]</xref>
###xml 175 176 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 219 223 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Scola1">[37]</xref>
###xml 240 242 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 303 307 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Delgado1">[38]</xref>
###xml 350 352 348 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 352 354 350 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 422 424 416 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 424 426 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 555 559 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Hussain2">[39]</xref>
###xml 603 605 593 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 711 713 697 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 713 715 699 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 717 724 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t005">Table 5</xref>
###xml 744 746 730 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 874 878 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Bagheri1">[18]</xref>
###xml 1143 1145 1125 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 1274 1278 1256 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Bagheri1">[18]</xref>
###xml 1412 1416 1394 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Mehdi1">[17]</xref>
A similar discrepancy is observed with IL10 (-1082 Glo-->Ahi) where no associations were reported in Gambian [35], Korean [36] and Spanish [23] populations. An association of A allele was observed in Italian (Sicilian) [37] population, and GA heterozygosity was associated with pulmonary TB in Cambodia [38]. Our results indicate that the homozygous GGlo increases the risk of DTB when it is associated with IFNgamma +874 AAlo phenotype (OR = 3.59; p = 0.045). This is consistent with the low levels of mycobacterial stimulated IFNgamma and IL10 from DTB [39]. We have observed an overrepresentation of GA heterozygous genotype in our study groups and may increase the risk of PMN when associated with IFNgamma AAlo (Table 5). The frequency of GA heterozygosity is highly variable in different populations ranging from 82.5% in Iranian population to 5% in Singapore Chinese [18]. Our results (70.2%) are closer to the Iranian population frequency. We further confirmed PCR amplified product by sequencing which also gave the expected SNP sequences for both IFNgamma and IL10 genotypes. Therefore, it is difficult to attribute the inflation in GA heterozygosity to artifacts in genotyping methodology as most studies have reported widely differing frequencies using ARMS PCR [18]. It is not unexpected to find linkage disequilibrium in consangious population such as the setting in which this study was conducted [17]. Further population-based studies are needed to address this issue.
###end p 28
###begin p 29
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Henao1">[29]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Jamil1">[16]</xref>
###xml 470 473 462 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Pacheco1">[9]</xref>
Nevertheless, a consensus seems to be emerging in that the combined effect of several cytokine SNPs may play a more crucial role in disease severity [29]. These results also substantiate our earlier report [16] that IFNgamma/IL10 ratio may be the critical determinant of clinical severity in both pulmonary and extra-pulmonary tuberculosis. A meta analyses recently published reinforces the critical importance of IFNgamma +874 T/A as a genetic marker for TB resistance [9], while IL10 indeed had some specific effect on TB determining the disease form and severity and not with susceptibility per se. Our results are consistent with these findings.
###end p 29
###begin p 30
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 491 499 <span type="species:ncbi:9606">patients</span>
If the rationale for analyzing cytokine gene polymorphism is to understand the pathogenesis of human disease, to identify potential markers of susceptibility or disease severity, responder vs. non-responders in therapeutic and vaccine trials, and to design novel strategies for intervention in high-risk groups, then the diversity of genetic associations warrants that such analyses are carried out in indigenous population. Our results further highlight the importance of stratification of patients in relation to disease severity, which otherwise mask the significance of associations in combined groups.
###end p 30
###begin title 31
Materials and Methods
###end title 31
###begin title 32
Subject studied
###end title 32
###begin p 33
###xml 105 112 105 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t001">Table 1</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Jamil1">[16]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Maher1">[40]</xref>
###xml 1010 1017 1010 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t002">Table 2</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 229 232 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 698 706 <span type="species:ncbi:9606">Patients</span>
###xml 864 872 <span type="species:ncbi:9606">patients</span>
Gene polymorphisms were analyzed in 376 donors (TB not affected, TBNA = 188 and TB affected, TBA = 188). Table 1 shows the breakdown of TB patients in terms of clinical severity: WHO guidelines for disease classification for non HIV related tuberculosis was adopted [16], [40] as follows. DTB (N = 20) had involvement of two or more sites with primary focus as meninges (N = 3), spinal (N = 1), intestinal (N = 11), splenic (N = 3) or miliary (N = 4) with or without lung involvement. PTB (N = 111) had involvement of lung parenchyma exclusively. LTB (N = 47) included TB restricted to one site without lung involvement (lymph nodes = 29, peripheral joints = 9, pleural = 8 and endobronchial = 1). Patients were included in the study if they were positive by one or more of the following criteria: microscopy, culture, histology, imaging (chestxrays for pulmonary patients and miliary involvement, CT scans for abdominal and skeletal and splenic involvement, MRI for meninges, or definitive clinical response (Table 2).
###end p 33
###begin title 34
Diagnostic modality used for confirmation of tuberculosis.
###end title 34
###begin p 35
Note: Primary diagnostic modality used diagnosis of tuberculosis.
###end p 35
###begin p 36
###xml 39 59 39 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
Criteria for disease category given in material and methods.
###end p 36
###begin p 37
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Imaging tests included chestxrays for pulmonary patients, CT scan and or MRI for disseminated disease.
###end p 37
###begin title 38
Genotype frequencies in healthy controls and different clinical forms of tuberculosis (TB).
###end title 38
###begin p 39
###xml 41 62 41 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 125 132 125 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t001">Table 1</xref>
###xml 6 13 <span type="species:ncbi:9606">Patient</span>
Note: Patient stratification is given in Materials and Methods. N for each group given in brackets. Abbreviations used as in Table 1. Number (frequency) of genotypes is indicated. Pearson chi analysis was carried to determine the significance of differences.
###end p 39
###begin p 40
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All significant p values are indicated in bold. P approaching significance is given in italics. p<0.05 is considered significant.
###end p 40
###begin title 41
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Differences in allele frequencies in healthy controls and tuberculosis patients
###end title 41
###begin p 42
###xml 41 61 41 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
###xml 127 134 127 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004778-t001">Table 1</xref>
###xml 6 13 <span type="species:ncbi:9606">Patient</span>
Note: Patient stratification is given in material and methods. N for each group is given in brackets. Abbreviations used as in Table 1.
###end p 42
###begin title 43
Genotype combination in relation to disease severity.
###end title 43
###begin p 44
###xml 515 526 <span type="species:ncbi:9606">participant</span>
The control group consisted of healthy donors (TBNA = 188) with no signs, symptoms or history of previous tuberculosis. Tuberculin skin tests (TST) positivity was assessed by administering five tuberculin units intracutaneously on the volar surface of the right arm. An induration of >/=10 mm was used as a cut for positive responses (TST+) which is considered to be indicative of latent infection. The Aga Khan University Ethical Review Committee (ERC) approved the project. Written consent was obtained, for each participant or his or her guardians in case of minors after explaining the purpose of the study.
###end p 44
###begin title 45
DNA Extraction
###end title 45
###begin p 46
Five ml blood were collected in ACD (VWR Scientific, West Chester, PA, USA) tubes and kept frozen until use. Genomic DNA was extracted from frozen whole blood using Promega Wizard Genomic DNA Purification Kit (Promega Corporation Madison, WI, USA) according to the manufacturer's instructions. After extraction, DNA was quantified by spectrophotometery, checked for purity and stored at -35degreesC until further analyses.
###end p 46
###begin title 47
Molecular analysis
###end title 47
###begin p 48
###xml 115 119 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Perrey1">[41]</xref>
###xml 218 223 <span type="species:ncbi:9606">Human</span>
IFNgamma and IL10 genotype analyses were carried out using amplification refractory mutation system-PCR (ARMS-PCR) [41]. Primers used for the detection of SNPs were purchased from MWG-Biotech AG, (Ebersberg, Germany). Human growth hormone and beta actin were used as internal controls to check the accuracy of PCR reactions. Amplified products were monitored by electrophoresis on agarose gel containing 10 mg/ml ethidium bromide. Product bands were visualized on a transiluminator and polaroid pictures were taken for interpretation.
###end p 48
###begin p 49
###xml 217 246 213 242 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAT GAT TCT GGC TAA GGA-3&#8242;</named-content>
###xml 267 299 259 291 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCC CAA TGG TAC AGG TTT CT-3&#8242;</named-content>
###xml 320 348 312 340 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGT GGA AGG GGA AGG TG-3&#8242;</named-content>
###xml 366 398 358 390 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAA AAG ATG GGG TGG AAG AA-3&#8242;</named-content>
###xml 1167 1169 1151 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 1176 1178 1160 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 1191 1193 1175 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 1199 1201 1183 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
Sequencing methodology was used as a second confirmatory method on a subset of samples to verify that correct alleles were being identified by ARMS-PCR. The primers used for sequencing analyses were IFNgamma Forward (5'-TAT GAT TCT GGC TAA GGA-3'), IFNgamma Reverse (5'-CCC CAA TGG TAC AGG TTT CT-3') and IL-10 Forward (5'-TGT GGA AGG GGA AGG TG-3'), IL-10 Reverse (5'-TAA AAG ATG GGG TGG AAG AA-3'). These primers were designed using software Lasergene version 7.0 (DNAstar, Madison, WI, USA) and amplify a part of the gene that covers IFNgamma (+874T-->A) or IL10 (-1082G-->A) SNPs to yield products size of 318 and 329 bp respectively. PCR products were purified with the QIAquick PCR purification kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Purified products were then sent to Macrogen for sequencing (Macrogen Inc, Seoul, Korea) with both forward and reverse primers. Sequencing results were analyzed by BLAST search of the GenBank database and EMBOSS pairwise alignment of the EMBL-EBI database. There was complete concordance between PCR based and sequence based analyses for homozygous as well as heterozygous genotypes (+874, TT = 13; AA = 9; -1082, GG = 6; GA = 17).
###end p 49
###begin title 50
Whole blood stimulation assays
###end title 50
###begin p 51
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Hussain1">[34]</xref>
Stimulated whole blood (WB) culture assay for assessing cytokine profiles have been described in detail previously [34]. Briefly, heparinized blood was diluted 1/11 with sterile RPMI 1640 tissue culture medium containing 100 units/ml of penicillin/100 microg/ml streptomycin and 2 mM L-glutamine (Sigma Chemical Co., St Louis, Mo). Diluted WB (900 microl/ well) were stimulated with MTB culture filtrate proteins [5 microg/m] in a 24-well tissue culture plates (Flow Laboratories, Irvine, Scotland) within 2 hours of collection. Supernatants were collected from the wells at varying intervals and stored as 4x200 microl aliquots at -35degreesC.
###end p 51
###begin title 52
Cytokine assessment
###end title 52
###begin p 53
###xml 130 134 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004778-Hussain2">[39]</xref>
Cytokine (IFNgamma and IL10) in supernatants were assessed using pairs of monoclonal antibodies as described in detail previously [39]. Dose response curves were set up in each individual plate. Supernatants were serially diluted and optical density readings in the linear range of the dose response curve were used for calculating the concentrations. The final concentrations (pg/ml) were obtained after multiplying the values by dilutions at which the OD was read. The sensitivity and range of cytokine detection was 7.5-1000 pg/ml and was comparable to that reported by the manufacturer.
###end p 53
###begin title 54
Statistical Analysis
###end title 54
###begin p 55
###xml 828 829 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 982 983 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 989 990 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 115 122 <span type="species:ncbi:9606">patient</span>
Allelic and genotypic frequencies and multi loci analysis were compared for all groups together and for individual patient and control groups. Computer software SPSS version 16.0 and Epi Info 2000 applications were used to carry out statistical analyses. Frequencies were compared between groups by Pearson chi-squared tests or Fisher's exact tests, when analyzing allelic frequencies lower than five to determine statistical significance differences between groups. Odds ratios (OR) with respective confidence intervals (95% CI) for disease susceptibly were also calculated. Linear-by-linear test were used to determine the significance (corrected p values) of genotypes between TB groups and healthy controls. Multiple logistic regression analysis was applied, to determine the effect of age and sex with genotypes. Values of p<0.05 were considered significant for both Pearson and linear-by-linear chi2 test. Hardy-Weinberg proportions were determined by applying the equation (p2+2pq+q2).
###end p 55
###begin p 56
###xml 133 141 <span type="species:ncbi:9606">patients</span>
We are grateful to Dr. Abbas Rehmani, Consultant Chest Physician, Rima Clinic, Karachi for providing blood samples from tuberculosis patients and Dr. Bushra Moiz of The Aga Khan University for providing samples from healthy donors. Excellent support for documentation of families by Miss Farida Talat and Ms Farzana Sohan (LHV) are gratefully acknowledged. We are grateful to Dr Philippe Frossard for critical comments on the manuscript. Excellent technical support by Mr. Mohammad Anwar for blood collection, and secretarial help by Ms Regina D'souza are gratefully acknowledged. We are also grateful to Ms Maqboola Dojki and Ms Firdaus Shahid for administrative support and Ms Nasira Asghar and Mr Iqbal Azam with help in statistical analysis. We acknowledge KIBGE, University of Karachi, for providing research and office space during Dr. Rabia Hussain's sabbatical during February-April 2005.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
###xml 53 79 53 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 53 79 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
A chain binomial model for intra-household spread of Mycobacterium tuberculosis in a low socio-economic setting in Pakistan.
###end article-title 58
###begin article-title 59
###xml 50 58 <span type="species:ncbi:9606">Patients</span>
Tuberculosis Trend among Household Contacts of TB Patients.
###end article-title 59
###begin article-title 60
Tuberculosis in Household Contacts of Infectious Cases in Kampala, Uganda.
###end article-title 60
###begin article-title 61
Risk of Tuberculosis among Household Contacts in Salvador, Bahia.
###end article-title 61
###begin article-title 62
Epidemiology of Tuberculosis.
###end article-title 62
###begin article-title 63
Immune factors and immunoregulation in tuberculosis.
###end article-title 63
###begin article-title 64
Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.
###end article-title 64
###begin article-title 65
###xml 126 131 <span type="species:ncbi:9606">child</span>
A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFN gamma in a compound heterozygous child.
###end article-title 65
###begin article-title 66
IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study.
###end article-title 66
###begin article-title 67
###xml 56 61 <span type="species:ncbi:9606">human</span>
A single nucleotide polymorphism in the first intron of human interferon g gene: absolute correlation with a polymorphic C/A microsatellite marker of high interferon g production.
###end article-title 67
###begin article-title 68
The interleukin 10-1082 G/A polymorphism: allele frequency in different populations and functional significance.
###end article-title 68
###begin article-title 69
Interleukin-10 and Tumor Necrosis Factor-a Gene Polymorphism in Tuberculosis.
###end article-title 69
###begin article-title 70
Polymorphism of interleukin-10 and tumour necrosis factor-a genes are associated with newly diagnosed and recurrent pulmonary tuberculosis.
###end article-title 70
###begin article-title 71
###xml 56 82 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
An Essential role for Interferon gamma in resistance to Mycobacterium tuberculosis infection.
###end article-title 71
###begin article-title 72
IL-10 producing and naturally occurring CD4+ Tregs: limiting collateral damage.
###end article-title 72
###begin article-title 73
Interferongamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis.
###end article-title 73
###begin article-title 74
###xml 16 21 <span type="species:ncbi:9606">Human</span>
Perspectives on Human Genome Diversity within Pakistan using Y Chromosomal and Autosomal Microsatellite Markers.
###end article-title 74
###begin article-title 75
Heterogeneity of cytokine single-nucleotide polymorphsims among the Iranian and in the other East-South Asian populations.
###end article-title 75
###begin article-title 76
Host Genetics and Susceptibility.
###end article-title 76
###begin article-title 77
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of the +874T->A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis.
###end article-title 77
###begin article-title 78
Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene.
###end article-title 78
###begin article-title 79
Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese.
###end article-title 79
###begin article-title 80
Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis 5691.
###end article-title 80
###begin article-title 81
Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis.
###end article-title 81
###begin article-title 82
Interferon-gamma gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response.
###end article-title 82
###begin article-title 83
Interferon-gamma gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis.
###end article-title 83
###begin article-title 84
No association between the +874T/A single nucleotide polymorphism in the IFN-g gene and susceptibility to TB.
###end article-title 84
###begin article-title 85
Interferon gamma (IFNgamma) & interleukin-4 (IL-4) gene variants & cytokine levels of pulmonary tuberculosis.
###end article-title 85
###begin article-title 86
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis.
###end article-title 86
###begin article-title 87
Polymorphism within the Interferon-g/ Receptor Complex is associated with Pulmonary Tuberculosis.
###end article-title 87
###begin article-title 88
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
###end article-title 88
###begin article-title 89
Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
###end article-title 89
###begin article-title 90
An Investigation of polymorphism in the interleukin-10 gene promoter.
###end article-title 90
###begin article-title 91
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Cytokine profiles using whole blood assays can discriminate between tuberculosis patients and healthy endemic controls in BCG-vaccinated population.
###end article-title 91
###begin article-title 92
Susceptibility to mycobacterial infections: the importance of host genetics.
###end article-title 92
###begin article-title 93
Common interleukin 10 polymorphism associated with deceased risk of tuberculosis.
###end article-title 93
###begin article-title 94
###xml 58 66 <span type="species:ncbi:9606">patients</span>
IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy.
###end article-title 94
###begin article-title 95
Ethnic-Specific genetic associations with pulmonary tuberculosis.
###end article-title 95
###begin article-title 96
Longitudinal tracking of cytokines after acute exposure to Tuberculosis: Association of Distinct Cytokine patterns with protection and disease development.
###end article-title 96
###begin article-title 97
Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumor necrosis factor-alpha genes: a technical report.
###end article-title 97
###begin p 98
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 98
###begin p 99
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by The Grant No PCST/NCB-AC3/2003 and by the Higher Education Commission of Pakistan Grant No 20-796/ R and D/07 Government of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 99

